Tumour escape: antitumour effectors too much of a good thing?

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.53, Iss.3, 2004-03, pp. : 262-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tumour escape from the immune response

By Pawelec G.

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 10, 2004-10 ,pp. : 843-843

Springer Publishing Company

Access to resources Recommend Favorite

Glycosidated Phospholipids – a Promising Group of Anti-Tumour Lipids

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 4, 2014-05 ,pp. : 607-617

Bentham Science Publishers

Access to resources Recommend Favorite

Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity

By Todryk Stephen Eaton Jonathan Birchall Lindsay Greenhalgh Rebecca Soars Diane Dalgleish Angus Melcher Alan Pandha Hardev

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 4, 2004-04 ,pp. : 323-330

Springer Publishing Company

Access to resources Recommend Favorite

Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

By Tímár József Győrffy Balázs Rásó Erzsébet

Clinical and Experimental Metastasis, Vol. 27, Iss. 6, 2010-08 ,pp. : 371-387

Springer Publishing Company

Access to resources Recommend Favorite

Paclitaxel in Advanced Ovarian Cancer: Too Much Optimism?

By Bulusu V.R. Allerton R.

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 335-335

Elsevier

Access to resources Recommend Favorite